🔗 Share this article

Chancellor Reeves has announced she is preparing "focused measures to address household expense challenges" in the upcoming Budget.

Speaking to media outlets, she noted that curbing inflation is a collective task of both the administration and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Utility Bill Measures

Sources suggest the administration could take action to bring down utility costs, for example by slashing the current 5% level of VAT charged on energy.

Another approach is to reduce some of the regulatory levies currently added to bills.

Budgetary Constraints and Expert Predictions

The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for such measures.

The expectation from the majority of analysts is that Reeves will have to declare tax increases or expenditure reductions in order to fulfill her self-imposed debt limits.

Previously on the same day, estimates suggested there was a twenty-two billion pound shortfall for the chancellor to address, which is at the lower end of forecasts.

"It is a shared task between the central bank and the government to continue tackling some of the sources of price increases," Reeves stated to reporters in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Issues

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not changed her pledge to campaign commitments not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with rising international and commercial issues for the fiscal tax moves, probably to be directed on those "wealthiest."

International Economic Disputes

Addressing worries about the United Kingdom's economic relations with the Asian nation she said: "Our national security invariably take priority."

Last week's announcement by China to tighten export controls on rare earths and other resources that are crucial for high-technology manufacturing led American leader Donald Trump to propose an further 100% import tax on imports from China, raising the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary called the Chinese move "economic coercion" and "a global supply chain control attempt."

Asked about considering the US offer to participate in its battle with China, Reeves said she was "deeply worried" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the international commerce and causes further obstacles."

"In my view there are sectors where we should address Chinese policies, but there are also significant opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to achieve that balance right."

The chancellor also stated she was working with other major economies "on our own essential resources strategy, so that we are more independent."

Health Service Drug Costs and Investment

The Chancellor also admitted that the price the National Health Service pays for medicines could rise as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or canceling investments in the UK, with several attributing the low prices they are getting.

Last month, the government science advisor said the price the health service spends on drugs would must increase to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves told media: "It has been observed as a result of the cost structure, that clinical trials, new drugs have not been offered in the United Kingdom in the way that they are in other continental states."

"We want to ensure that people receiving care from the NHS are can access the finest essential medicines in the globe. And so we are reviewing all of that, and... seeking to obtain more funding into the UK."